| |
| |
|
| Insider
Information: |
Anzalone Christopher Richard |
| Relationship: |
Chief Executive Office... |
| City: |
Pasadena |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,715,048 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$92,876,200 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,715,048 |
|
|
| Total
Value |
$92,876,200 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -37.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arrowhead Pharmaceuticals Inc |
ARWR |
Chief Executive Office... |
2024-01-31 |
3,715,048 |
2008-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
President and CEO |
• • – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
210,000 |
244,173 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
President and CEO |
• • – |
2015-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
360,000 |
620,173 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
540,000 |
1,101,461 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2017-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
978,000 |
1,794,789 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
2,294,789 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
600,000 |
2,142,455 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2020-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
900,000 |
2,705,237 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
800,000 |
4,045,828 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
18,375 |
3,486,689 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2022-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
234,025 |
3,720,714 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-03-13 |
4 |
AS |
$7.43 |
$743,000 |
D/D |
(100,000) |
2,194,789 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-03-14 |
4 |
AS |
$7.44 |
$744,000 |
D/D |
(100,000) |
2,094,789 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-03-15 |
4 |
AS |
$7.41 |
$741,000 |
D/D |
(100,000) |
1,994,789 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-03-16 |
4 |
AS |
$7.40 |
$192,400 |
D/D |
(26,000) |
1,968,789 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-08-31 |
4 |
AS |
$14.45 |
$1,445,000 |
D/D |
(100,000) |
1,868,789 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-09-04 |
4 |
AS |
$14.45 |
$936,851 |
D/D |
(64,834) |
1,803,955 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-11-09 |
4 |
AS |
$14.35 |
$1,172,705 |
D/D |
(81,500) |
1,722,455 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-12-12 |
4 |
AS |
$14.07 |
$1,266,300 |
D/D |
(90,000) |
1,632,455 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2018-12-19 |
4 |
AS |
$13.92 |
$1,252,800 |
D/D |
(90,000) |
1,542,455 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-12-02 |
4 |
AS |
$66.58 |
$2,625,570 |
D/D |
(37,967) |
2,083,936 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-12-03 |
4 |
AS |
$60.73 |
$740,952 |
D/D |
(12,033) |
2,071,903 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-12-12 |
4 |
AS |
$66.82 |
$6,749,630 |
D/D |
(100,000) |
1,971,903 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-12-13 |
4 |
AS |
$65.85 |
$5,560,489 |
D/D |
(83,333) |
1,888,570 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2019-12-24 |
4 |
AS |
$63.50 |
$5,291,646 |
D/D |
(83,333) |
1,805,237 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
• • – |
2020-06-25 |
4 |
AS |
$38.81 |
$3,881,017 |
D/D |
(100,000) |
2,605,237 |
0 |
% |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
